These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33800135)

  • 1. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo.
    Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.
    Colarusso A; Maroccia Z; Parrilli E; Germinario EAP; Fortuna A; Loizzo S; Ricceri L; Tutino ML; Fiorentini C; Fabbri A
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32375387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model.
    Vannini E; Panighini A; Cerri C; Fabbri A; Lisi S; Pracucci E; Benedetto N; Vannozzi R; Fiorentini C; Caleo M; Costa M
    BMC Cancer; 2014 Jun; 14():449. PubMed ID: 24939046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function.
    Vannini E; Olimpico F; Middei S; Ammassari-Teule M; de Graaf EL; McDonnell L; Schmidt G; Fabbri A; Fiorentini C; Baroncelli L; Costa M; Caleo M
    Neuro Oncol; 2016 Dec; 18(12):1634-1643. PubMed ID: 27298309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages.
    Vannini E; Maltese F; Olimpico F; Fabbri A; Costa M; Caleo M; Baroncelli L
    Oncotarget; 2017 Apr; 8(14):23539-23550. PubMed ID: 28212563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
    Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
    Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential.
    Xu T; Fan Z; Li W; Dietel B; Wu Y; Beckmann MW; Wrosch JK; Buchfelder M; Eyupoglu IY; Cao Z; Savaskan NE
    Sci Rep; 2016 Feb; 6():19799. PubMed ID: 26831010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-gliomas Effect of Chlorotoxin-Conjugated Onconase at High Dose.
    Wang X; Guo Z
    Cell Biochem Biophys; 2015 Nov; 73(2):389-392. PubMed ID: 27352327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of chlorotoxin for targeting of primary brain tumors.
    Soroceanu L; Gillespie Y; Khazaeli MB; Sontheimer H
    Cancer Res; 1998 Nov; 58(21):4871-9. PubMed ID: 9809993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1).
    Tantillo E; Colistra A; Vannini E; Cerri C; Pancrazi L; Baroncelli L; Costa M; Caleo M
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cytochrome c-Chlorotoxin Hybrid Protein as a Possible Antiglioma Drug.
    Delinois LJ; Peón H; Villalobos-Santos JC; Ramírez-Paz J; Miller J; Griebenow KH; Tinoco AD
    ChemMedChem; 2020 Nov; 15(22):2185-2192. PubMed ID: 32918396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
    ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery.
    Zhao L; Zhu J; Gong J; Song N; Wu S; Qiao W; Yang J; Zhu M; Zhao J
    J Nanobiotechnology; 2020 Oct; 18(1):143. PubMed ID: 33054757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli.
    Zhang Z; Aung KM; Uhlin BE; Wai SN
    Sci Rep; 2018 Dec; 8(1):17780. PubMed ID: 30542142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.
    Davis JM; Carvalho HM; Rasmussen SB; O'Brien AD
    Infect Immun; 2006 Aug; 74(8):4401-8. PubMed ID: 16861625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.
    Pavone F; Luvisetto S; Marinelli S; Straface E; Fabbri A; Falzano L; Fiorentini C; Malorni W
    Pain; 2009 Sep; 145(1-2):219-29. PubMed ID: 19608345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma.
    Zhao L; Shi X; Zhao J
    Curr Top Med Chem; 2015; 15(13):1196-208. PubMed ID: 25858130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
    Huang R; Ke W; Han L; Li J; Liu S; Jiang C
    Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.